Percutaneous left atrial appendage closure with complex anatomy by using the staged 'kissing-Watchman' technology with double devices

被引:17
作者
Jiang, Lisheng [1 ,2 ]
Duenninger, Erich [1 ]
Muenzel, Manuela [1 ]
Xue, Xin [1 ,3 ]
Fazakas, Adam [1 ]
Keil, Thorsten [4 ]
Yu, Jiangtao [1 ]
机构
[1] Helmut G Walther Klinikum, Dept Cardiol, D-96215 Lichtenfels, Germany
[2] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Cardiol, Shanghai, Peoples R China
[3] Jilin Univ, Hosp 2, Dept Cardiol, Changchun, Jilin, Peoples R China
[4] Helmut G Walther Klinikum, Dept Anesthesiol, Lichtenfels, Germany
关键词
FIBRILLATION; WARFARIN;
D O I
10.1016/j.ijcard.2018.05.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Left atrial appendage closure (LAAC) is an efficient alternative of oral anticoagulation to prevent stroke in patients with non-valvular atrial fibrillation (NVAF). Due to complexities of LAA anatomy, a complete closure may not always be obtained with a single device. The aim of this study was to evaluate the feasibility and safety of the staged 'kissing-Watchman' technology to occlude the LAA with complex anatomy. Methods: In our center, among 300 cases underwent LAAC with Watchman device from February 2012 to December 2016, 7 complex LAAs were implanted double devices using the staged 'kissing-Watchman' technology. The anatomic morphology, procedure characteristics and safety were analyzed. Results: Of the 7 LAAs, the anatomic morphology includes 6 cauliflowers and 1 chicken wings, each has 2 big lobes and a large common ostium. In the two-staged LAAC procedures, there were no differences in X-ray exposure time, but the total procedure time (p = 0.0634), contrast volume (p = 0.0802) and X-ray dose (p = 0.0803) in the first procedure showed a tendency over the second. All the procedures were successful, except for one case with a 2mmof peri-device leakage, there were no severe complications or major adverse events including device dislocation, thrombosis, obvious peri-device leakage (= 5 mm), pericardial effusion/tamponade, stroke/transient ischemic attack/systemic embolism, death and major bleeding during the 7-day perioperative period and the 6-month follow-up. Conclusions: The staged 'kissing-Watchman' technology is feasible and safe, which might provide a strategy to occlude the LAA with complex anatomy when an incomplete closure is inevitable with a single device. (C) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:58 / 61
页数:4
相关论文
共 13 条
[1]   Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indication [J].
Boersma, Lucas V. ;
Barr, Craig S. ;
Burke, Martin C. ;
Leon, Angel R. ;
Theuns, Dominic A. ;
Herre, John M. ;
Weiss, Raul ;
Kremers, Mark S. ;
Neuzil, Petr ;
Husby, Michael P. ;
Carter, Nathan ;
Stivland, Timothy M. ;
Gold, Michael R. .
HEART RHYTHM, 2017, 14 (03) :367-375
[2]  
Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/europace/eus305, 10.1093/eurheartj/ehs253]
[3]   Double device left atrial appendage closure [J].
Guerios, Enio E. ;
Gloekler, Steffen ;
Schmid, Michael ;
Khattab, Ahmed ;
Nietlispach, Fabian ;
Meier, Bernhard .
EUROINTERVENTION, 2015, 11 (04) :470-476
[4]   Analysis of the left atrial appendage by magnetic resonance angiography in patients with atrial fibrillation [J].
Heist, E. Kevin ;
Refaat, Marwan ;
Danik, Stephan B. ;
Homvang, Godtfred ;
Ruskin, Jeremy N. ;
Mansour, Moussa .
HEART RHYTHM, 2006, 3 (11) :1313-1318
[5]   Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial [J].
Holmes, David R. ;
Reddy, Vivek Y. ;
Turi, Zoltan G. ;
Doshi, Shephal K. ;
Sievert, Horst ;
Buchbinder, Maurice ;
Mullin, Christopher M. ;
Sick, Peter .
LANCET, 2009, 374 (9689) :534-542
[6]   Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy [J].
Holmes, David R., Jr. ;
Kar, Saibal ;
Price, Matthew J. ;
Whisenant, Brian ;
Sievert, Horst ;
Doshi, Shephal K. ;
Huber, Kenneth ;
Reddy, Vivek Y. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (01) :1-12
[7]  
Kirchhof P, 2016, EUROPACE, V18, DOI [10.5603/KP.2016.0172, 10.1093/europace/euw295, 10.1016/j.rec.2016.11.033]
[8]   5-Year Outcomes After Left Atrial Appendage Closure From the PREVAIL and PROTECT AF Trials [J].
Reddy, Vivek Y. ;
Doshi, Shephal K. ;
Kar, Saibal ;
Gibson, Douglas N. ;
Price, Matthew J. ;
Huber, Kenneth ;
Horton, Rodney P. ;
Buchbinder, Maurice ;
Neuzil, Petr ;
Gordon, Nicole T. ;
Holmes, David R., Jr. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (24) :2964-2975
[9]   Percutaneous Left Atrial Appendage Closure vs Warfarin for Atrial Fibrillation A Randomized Clinical Trial [J].
Reddy, Vivek Y. ;
Sievert, Horst ;
Halperin, Jonathan ;
Doshi, Shephal K. ;
Buchbinder, Maurice ;
Neuzil, Petr ;
Huber, Kenneth ;
Whisenant, Brian ;
Kar, Saibal ;
Swarup, Vijay ;
Gordon, Nicole ;
Holmes, David .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (19) :1988-1998
[10]   Effect of study setting on anticoagulation control - A systematic review and metaregression [J].
van Walraven, Carl ;
Jennings, Alison ;
Oake, Natalie ;
Fergusson, Dean ;
Forster, Alan J. .
CHEST, 2006, 129 (05) :1155-1166